Example

The network is joined by two full industrial partners, AstraZeneca (AZ) and Almac and by two associate partners, F2 Chemicals and Bruker.

AstraZeneca

One of the world’s largest pharmaceutical companies with a very broad research and development programme, AstraZeneca will be a fully integrated partner in the network. They will act as lead supervisor on an individual research project (ER1 – 24 months) while also providing scientific expertise to other network projects in the form of ESR co-supervision, training and the facilitating of secondments.

Almac

Almac provides services for all stages of drug development for small molecules (including highly potent and cytotoxic) and peptides. Almac will be a fully integrated network partner, acting as lead supervisor on an individual research project (ER2 - 24 months). Almac will also provide expertise and support to other projects within the network. They will co-supervise ESR projects and contribute to training and research workshops and facilitate secondments.

F2 Chemicals

Experts in the exploitation and application of fluorine gas as a chemical reagent, F2 Chemicals will play a key role within ESR/ER training. In this capacity they will contribute to various training and research workshops while also providing technical expertise and support to secondments of various ESRs.

Bruker

Bruker is a manufacturer of scientific instruments and has been developing products for magnetic resonance for over 50 years (both NMR and MRI systems). Bruker will play a vital role within ESR/ER training; providing training and research workshops in the areas of 19F NMR. They will also provide cutting edge technical expertise and support for secondments of various ESR/ERs to use specialized instrumentation.